Rectus femoris muscle and phase angle as prognostic factor for 12-month mortality in a longitudinal cohort of patients with cancer (anyvida trial)

HIGHLIGHTS

• who: Cristina Garcu00eda-Garcu00eda et al. from the Facultad Medicina, Universidad of Mu00e1laga, Mu00e1laga, Spain have published the article: Rectus Femoris Muscle and Phase Angle as Prognostic Factor for 12-Month Mortality in a Longitudinal Cohort of Patients with Cancer (AnyVida Trial), in the Journal: Nutrients 2023, 15, x FOR PEER REVIEW of 27/Nov/2022
• what: The aim of this study is to evaluate the prognostic value of classic and emerging assessment of malnutrition at 12-months survival in cancer patients.
• how: The authors conducted a prospective study on cancer outpatients. To . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.